Hormones, Cognition and Dementia (eBook, PDF)

State of the Art and Emergent Therapeutic Strategies
Redaktion: Hogervorst, Eef

• Format: PDF

Produktbeschreibung

A decade ago, oestrogen-containing hormone therapy was viewed as a promising strategy for the prevention and treatment of dementia and age-related cognitive decline. However, treatment trials in women with Alzheimer's disease showed that oestrogens did not reverse cognitive impairment, and clinical trials in healthy older women indicated that oestrogens did not prevent cognitive decline. The Women's Health Initiative Memory Study trial even suggested an increased risk of dementia with treatment late in life. What happened? How are we to understand these findings? What are the implications for middle-aged and older women? What about testosterone, and what about men? And where do we go from here? This book brings together world-renowned experts in basic and clinical research on sex steroids, aging, and cognition to integrate existing findings with emerging new data, and offer challenging hypotheses on these key issues.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 24. September 2009
• Englisch
• ISBN-13: 9780511630385
• Artikelnr.: 38186047

Inhaltsangabe

Preface; Part I. Estrogens and Cognition: 1. Women's Health Initiative
Memory Study (WHIMS) program; 2. Identifying risk-factors for cognitive
change in the Women's Health Initiative; 3. Estrogen therapy - relationship
to longevity and prevalent dementia in the oldest-old; 4. The critical
window hypothesis: hormone exposures and cognitive outcomes after
menopause; 5. Animal studies that support estrogen effects on cognitive
performance and the cholinergic basis of the critical period hypothesis;
Part II. Varieties of Estrogenic Therapy: 6. The healthy cell bias of
estrogen action through regulating glucose metabolism and mitochondrial
function; 7. Alternative estrogenic treatment regimes and the Kronos Early
Estrogen Prevention Study-Cognitive and Affective Substudy (KEEPS-CA); 8.
The use of transdermal 17-estradiol in the treatment of Alzheimer's
disease; 9. Alternative modes of treatment: pulsatile estradiol treatment;
10. In search of estrogen alternatives for the brain; Part III. Potential
Modulators and Modifiers of Estrogenic Effects: 11. Progesterone regulation
of neuroprotective estrogen actions; 12. Clinical data of estrogen's
effects in the central nervous system; 13. Different forms of soy
processing may determine the positive or negative impact on cognitive
function of Indonesian elderly; 14. Hypothalamus-pituitary-adrenal axis
activity in aging women; Part IV. Possible Genetic Factors Related to
Hormone Treatment Effects: 15. Possible genetic polymorphisms related to
sex steroid metabolism and dementia in women; 16. Genetics related to sex
steroids: implications for Alzheimer's disease; 17. Apolipoprotein E,
hormone therapy and neuroprotection; 18. Testosterone, gonadotrophins and
genetic polymorphisms in men with Alzheimer's disease; Part V.
Testosterone, Estradiol and Men, and Sex Hormone Binding Globulin: 19.
Androgens and cognitive functioning in women; 20. The role of estradiol in
testosterone treatment; 21. Endogenous testosterone levels and cognitive
aging in men; 22. Clinical trials and neuroimaging studies of testosterone
in men: insights into effects on verbal memory; 23. Testosterone therapy
and Alzheimer's disease: potential for treatment and prevention in women;
24. Endogenous estradiol and dementia in elderly men: the roles of vascular
risk, sex hormone binding globulin, and aromatase activity; 25.
Testosterone regulates Alzheimer's disease pathogenesis; Part VI.
Gonadotropin Effects: 26. Involvement of gonadotropins in cognitive
function: implications for Alzheimer's disease; 27. The role of
gonadotropins and testosterone in the regulation of beta amyloid
metabolism; 28. Epilogue; 29. Concluding remarks; Index.